通策医疗: insider trades · France · AMF SSE:600763 FR FR · AMF Mcap 18.0Bn€
Discover the full insider trade history of 通策医疗, a listed equity based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €18bn. The latest transaction was filed on 27 March 2026 — Purchase. Among the most active insiders: 吕建明. All data is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 2.91 Bn€
Gross profit 1.13 Bn€ 39% margin
Net income 501.9 M€ 17.2% margin
Balance sheet & cash
Market cap 17.99 Bn€
Total debt 1.11 Bn€
Free Cash Flow 564.5 M€
Last declaration on 27 March 2026
Declarations 9 total
Executives ● Purchase7 SSE
24,100 shares
SSE:273000000313913820 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase7 SSE
9,300 shares
SSE:273000000314089800 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase7 SSE
4,600 shares
SSE:173000007174832350 · 18 Dec 2023
Ideal exit: 13 Sept 2024 (T+270) Executives ● Purchase10 SSE
19,200 shares
SSE:173000007032490880 · 26 Oct 2023
Ideal exit: 22 Jul 2024 (T+270) Executives ● Purchase7 SSE
30,000 shares
SSE:173000005387023230 · 28 Mar 2022
Ideal exit: 23 Dec 2022 (T+270) Executives ● Purchase7 SSE
8,700 shares
SSE:173000005360532350 · 15 Mar 2022
Ideal exit: 10 Dec 2022 (T+270) Executives ● Purchase7 SSE
10,000 shares
SSE:173000005310690660 · 24 Feb 2022
Ideal exit: 21 Nov 2022 (T+270) Executives ● Purchase7 SSE
16,000 shares
SSE:173000005304016060 · 21 Feb 2022
Ideal exit: 18 Nov 2022 (T+270) Executives ● Purchase7 SSE
42,000 shares
SSE:173000005290490140 · 16 Feb 2022
Ideal exit: 13 Nov 2022 (T+270)
